In today’s Weekly Video small-cap and early-stage stock analyst Tyler Laundon talks about one of the biggest trends out there – the race to bring Covid-19 vaccines and therapies to market. He highlights the bioprocessors as crucial players as the world tries to get 13 billion vaccine doses to market by the end of 2021. Stocks discussed include: TMO, DHR, RGEN.
Get It While It’s Hot!
Be among the first to see the Cabot Weekly Review when it comes out. Have it delivered right to your inbox every Saturday. Get on the list:
Tyler Laundon is chief analyst of Cabot Small-Cap Confidential. The circulation of Small-Cap Confidential is strictly limited because the undiscovered stocks with sky-high-potential that Tyler recommends are often low-priced and thinly traded. Don’t share these recommendations!Learn More